DE60126802D1 - Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese - Google Patents

Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese

Info

Publication number
DE60126802D1
DE60126802D1 DE60126802T DE60126802T DE60126802D1 DE 60126802 D1 DE60126802 D1 DE 60126802D1 DE 60126802 T DE60126802 T DE 60126802T DE 60126802 T DE60126802 T DE 60126802T DE 60126802 D1 DE60126802 D1 DE 60126802D1
Authority
DE
Germany
Prior art keywords
cyclopeptides
preparation
inhibiting
angiogenesis
stimulating angiogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60126802T
Other languages
English (en)
Other versions
DE60126802T2 (de
Inventor
Natacha Betz
Andreas Bikfalvi
Gerard Deleris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Victor Segalen Bordeaux 2
Universite des Sciences et Tech (Bordeaux 1)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Universite Victor Segalen Bordeaux 2
Commissariat a lEnergie Atomique CEA
Universite des Sciences et Tech (Bordeaux 1)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Victor Segalen Bordeaux 2, Commissariat a lEnergie Atomique CEA, Universite des Sciences et Tech (Bordeaux 1) filed Critical Universite Victor Segalen Bordeaux 2
Application granted granted Critical
Publication of DE60126802D1 publication Critical patent/DE60126802D1/de
Publication of DE60126802T2 publication Critical patent/DE60126802T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60126802T 2000-10-04 2001-10-02 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese Expired - Lifetime DE60126802T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0012654 2000-10-04
FR0012654A FR2814744B1 (fr) 2000-10-04 2000-10-04 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese
PCT/FR2001/003049 WO2002028895A2 (fr) 2000-10-04 2001-10-02 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese

Publications (2)

Publication Number Publication Date
DE60126802D1 true DE60126802D1 (de) 2007-04-05
DE60126802T2 DE60126802T2 (de) 2007-11-08

Family

ID=8854977

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60126802T Expired - Lifetime DE60126802T2 (de) 2000-10-04 2001-10-02 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese

Country Status (15)

Country Link
US (2) USRE44022E1 (de)
EP (1) EP1328546B1 (de)
JP (1) JP4303958B2 (de)
AT (1) ATE354589T1 (de)
AU (2) AU9394801A (de)
CA (1) CA2424506A1 (de)
DE (1) DE60126802T2 (de)
DK (1) DK1328546T3 (de)
ES (1) ES2282293T3 (de)
FR (1) FR2814744B1 (de)
IL (1) IL155117A0 (de)
NO (1) NO20031377L (de)
NZ (1) NZ525069A (de)
RU (1) RU2249599C2 (de)
WO (1) WO2002028895A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
EP1587944A4 (de) 2002-03-01 2007-03-21 Dyax Corp Kdr und vegf/kdr-bindende peptide und ihre diagnostische und therapeutische veranwendung bei der diagnose und therapie
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
ES2396368T3 (es) * 2003-03-03 2013-02-21 Dyax Corporation Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos
WO2007082890A1 (en) * 2006-01-17 2007-07-26 N.V. Organon SELECTIVE ENZYMATIC HYDROLYSIS OF C-TERMINAL tert-BUTYL ESTERS OF PEPTIDES
EP2106404A2 (de) 2006-10-19 2009-10-07 Ramot at Tel Aviv University Ltd. Zusammensetzungen und verfahren zur induktion von angiogenese
EP2456784B1 (de) * 2009-07-24 2017-01-11 Advanced Accelerator Applications S.A. Verbindungen als modulatoren der vegf-aktivität und ihre verwendung
FR2969999B1 (fr) 2011-01-03 2013-02-08 Commissariat Energie Atomique Conjugue, son procede de preparation et ses utilisations
US9815867B2 (en) 2012-09-03 2017-11-14 The University Of Tokyo Peptide for inhibiting vascular endothelial growth factor receptor
CN103724290B (zh) * 2013-11-15 2015-04-29 浙江大学 一种环肽化合物clavatustide A及其产生菌、制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
EP0844252A3 (de) * 1996-11-15 1998-07-08 Remacle, José Zyklische Peptide mit einer zur anschliessenden chemischen Kupplung entworfenen Zweiggruppe und Verfahren zu deren Herstellung
AU757554B2 (en) * 1998-02-11 2003-02-27 Bracco International B.V. Angiogenesis targeting molecules
JP2002538219A (ja) * 1999-03-11 2002-11-12 エントレメッド インコーポレイテッド 癌及び高増殖性疾患治療用の組成物及び方法

Also Published As

Publication number Publication date
WO2002028895A3 (fr) 2002-06-06
DE60126802T2 (de) 2007-11-08
ES2282293T3 (es) 2007-10-16
NZ525069A (en) 2004-09-24
JP4303958B2 (ja) 2009-07-29
CA2424506A1 (en) 2002-04-11
US7199100B2 (en) 2007-04-03
DK1328546T3 (da) 2007-06-04
FR2814744B1 (fr) 2002-11-29
RU2249599C2 (ru) 2005-04-10
EP1328546A2 (de) 2003-07-23
ATE354589T1 (de) 2007-03-15
NO20031377L (no) 2003-05-02
JP2004510784A (ja) 2004-04-08
EP1328546B1 (de) 2007-02-21
USRE44022E1 (en) 2013-02-19
US20040092434A1 (en) 2004-05-13
AU9394801A (en) 2002-04-15
WO2002028895A2 (fr) 2002-04-11
NO20031377D0 (no) 2003-03-26
IL155117A0 (en) 2003-10-31
AU2001293948B2 (en) 2005-11-03
FR2814744A1 (fr) 2002-04-05

Similar Documents

Publication Publication Date Title
DE60126802D1 (de) Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese
ATE345682T1 (de) In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
AU2003264419A1 (en) Kdr peptides and vaccines containing the same
DE69925156D1 (de) Verfahren und zusammensetzungen zur behandlung von zellproliferationsstörungen
SE9300140D0 (sv) Solid substrate
AU1530401A (en) Security system
PT989858E (pt) Compostos que imitam os peptideos inibidores de cd28/ctla-composicoes farmaceuticas feitas a partir dos referidos e um metodo de usar os referidos
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
ATE233784T1 (de) Verfahren zur proteinaufreinigung aus einer proteinhaltigen lösung
NO981748L (no) Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette
PT1024822E (pt) Cd8 como inibidor do sistema imunitario celular
ATE332379T1 (de) Menschliche dnase resistent gegen actininhibitoren
FI952094A0 (fi) Ihmisen serotoniinireseptoria (5-HT4B)koodaava DNA ja sen käyttö
DE69923460D1 (de) Verfahren zur herstellung von ring-modifizierten zyklischen peptidanalogen
BR0317537A (pt) Processo para preparar aminoácidos em organismos transgênicos, construção de ácido nucleico, vetor, organismo procariótico ou eucariótico transgênico, uso dos organismos transgênicos, e, sequencia de aminoácidos
AU6378994A (en) Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter
ATE291088T1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
ATE296886T1 (de) Männliche fertilität vermittelnde nukleotidsequenzen und verfahren zu ihrer verwendung
ATE160355T1 (de) Verfahren zur reinigung von 1- n(2 -((s)- ethoxycarbonyl)-3-phenylpropyl)-n6 - trifluoraceytl>-l-lysyl-l-prolin (lisinopril(tfa)ethylester)
ATE212382T1 (de) Verfahren zur sequenzierung durch oligomerhybridisierung
DE60219361D1 (de) Verfahren zur rekombinanten herstellung von plazenta wachstumsfaktor
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
SE9401380D0 (sv) Ny celltillväxt-relaterad peptid och användning därav
ATE325812T1 (de) Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors
ATE401408T1 (de) Tapetum-spezifische promotoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition